Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: Multivariate analysis
Authors:
- Neelam G. ShahNSNeelam G. Shah
- Devendra D. PatelDPDevendra D. Patel
- Trupti I. TrivediTTTrupti I. Trivedi
- 24 December 2002
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 82 (1) , 34-50
Abstract
Background and Objectives Expression of a panel of biomarkers, such as p53, Bcl-2, Cyclin D1, c-myc, p21ras, c-erb B2, cytokeratin-19 (CK-19), and factor VIII–related antigen (FVIII-RA), was studied together in anterior tongue tumors from the oral cavity and in posterior tongue tumors from the oropharynx of patients with early- and locally advanced-stage disease, to evaluate their prognostic value. Methods The expression of the above-mentioned biomarkers was studied by immunohistochemical localization. Results In this study, 18%, 26%, 62%, 75%, 73%, 50%, and 29% of the tumors exhibited p53, Bcl-2, Cyclin D1, c-myc, p21ras, c-erb B2, and CK-19 expression, respectively. Twenty percent of the tumors had a microvessel count of >0.0. The expression of these biomarkers was also correlated with clinicopathologic parameters. In early-stage patients with a tobacco habit, who showed borderline significance for relapse-free survival by Kaplan-Meier survival analysis, this turned out to be significant, with the general linear model univariate survival analysis. In the total group, disease stage emerged as the most significant prognostic factor, followed by c-myc, when Cox forward stepwise regression and general linear model multivariate survival analysis were performed. However, Cyclin D1, which was significant by Cox forward stepwise regression analysis, lost its significance by general linear model multivariate analysis. In patients with early-stage disease, MVC, which was a significant predictor of disease relapse by Cox forward stepwise regression analysis, lost its significance by general linear model analysis because of small number of patients. In patients with locally advanced tongue cancer, multivariate survival analysis of individual biomarkers by both Cox forward stepwise regression and general linear model analysis indicated c-myc expression to be strongly indicative of poor prognosis. However, multivariate analysis of individual markers along with a combination of markers showed that only by Cox forward stepwise regression analysis did the combined expression of markers c-myc, Cyclin D1, and p21ras emerge as a significant independent prognosticator. Conclusions Overall stage emerged as the most significant prognostic indicator of disease outcome. Tobacco habit also affected relapse-free survival in patients with early-stage disease. However, immunostaining of c-myc in the tumors of locally advanced-stage tongue cancer patients might be a potential adjunct to clinical stage in the pathologic evaluation of tongue specimens. J. Surg. Oncol. 2003;82:34–50.Keywords
This publication has 31 references indexed in Scilit:
- Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neckHead & Neck, 1995
- Overexpression of the p53 gene in primary and metastatic head and neck carcinomasThe Laryngoscope, 1995
- Overexpression of p53 protein in betel‐ and tobacco‐related human oral dysplasia and squamous‐cell carcinoma in IndiaInternational Journal of Cancer, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Mammalian G1 cyclinsCell, 1993
- Cytokeratin expression in normal and (pre)malignant head and neck epithelia: An overviewHead & Neck, 1993
- Overexpression of P53 in head and neck cancerHead & Neck, 1992
- Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neckOral Oncology, 1992
- Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomasInternational Journal of Cancer, 1991
- Oncogene Amplification in Squamous Cell Carcinoma of the Oral CavityJapanese Journal of Cancer Research, 1989